Lymphocyte Activation Gene 3 (LAG-3) Protein Market
According to Intent Market Research, the Lymphocyte Activation Gene 3 Protein Market is expected to grow from USD 0.6 Billion in 2024-e at a CAGR of 23.7% to touch USD 2.0 Billion by 2030. The Lymphocyte Activation Gene 3 Protein Market is dominated by key players such as, Bristol-Myers Squibb, Novartis AG, Roche Holding AG, AstraZeneca, Merck & Co., and Sanofi.